CX3CR1 and metabolic dysfunction-associated steatohepatitis: Indeed, the level of circulating endotoxin in NASH patients is higher than that of healthy individuals.[14] Endotoxin can induce inflammatory reaction by activating hepatitis cells.[15] According to studies published in 2015, CX3C chemokine receptor 1 plays a role in controlling intestinal barrier permeability.